Standout Papers

Standardized image interpretation and post processing in cardiovascular m... 2009 2026 2014 2020 1.1k
  1. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing (2013)
    Jeanette Schulz‐Menger, David A. Bluemke et al. Journal of Cardiovascular Magnetic Resonance
  2. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation (2018)
    Vanessa M. Ferreira, Jeanette Schulz‐Menger et al. Journal of the American College of Cardiology
  3. Criteria for Evaluation of Novel Markers of Cardiovascular Risk (2009)
    Mark A. Hlatky, Philip Greenland et al. Circulation
  4. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update (2020)
    Christopher M. Kramer, Jörg Barkhausen et al. Journal of Cardiovascular Magnetic Resonance
  5. ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance (2010)
    W. Gregory Hundley, David A. Bluemke et al. Circulation
  6. Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update (2020)
    Jeanette Schulz‐Menger, David A. Bluemke et al. Journal of Cardiovascular Magnetic Resonance
  7. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update (2013)
    Christopher M. Kramer, Jörg Barkhausen et al. Journal of Cardiovascular Magnetic Resonance
  8. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols (2008)
    Christopher M. Kramer, Jörg Barkhausen et al. Journal of Cardiovascular Magnetic Resonance
  9. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Stable Ischemic Heart Disease (2013)
    Michael J. Wolk, Steven R. Bailey et al. Journal of the American College of Cardiology
  10. Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity (2024)
    Milton Packer, Michael R. Zile et al. New England Journal of Medicine
  11. Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure (2024)
    Christopher M. Kramer, Barry A. Borlaug et al. Journal of the American College of Cardiology
  12. Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial (2024)
    Barry A. Borlaug, Michael R. Zile et al. Nature Medicine

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 99 standout
Sub-graph 1 of 13

Citing Papers

Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
2025 Standout
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches
2023 Standout
2 intermediate papers

Works of Christopher M. Kramer being referenced

A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery disease
2019
The MOGE(S) Classification for a Phenotype–Genotype Nomenclature of Cardiomyopathy
2013
and 2 more

Author Peers

Author Last Decade Papers Cites
Christopher M. Kramer 9743 12450 3977 358 18.9k
Michael Jerosch‐Herold 7747 8562 2125 295 13.8k
Matthias G. Friedrich 10016 13061 3178 348 18.3k
Jeanette Schulz‐Menger 8223 11390 2315 279 15.4k
Sven Plein 10481 9832 2907 482 15.7k
Andrew E. Arai 10351 8873 2197 298 16.2k
Albert C. van Rossum 8009 9698 3342 475 14.4k
Paolo G. Camici 10863 14837 5963 339 21.7k
Eike Nagel 13976 12127 3724 423 20.6k
Ernst E. van der Wall 10310 19556 6489 668 26.7k
Warren J. Manning 14088 16692 4266 477 27.7k

All Works

Loading papers...

Rankless by CCL
2026